Table 1 Baseline characteristics by therapy

N

100

230

121

1967

Age, years

59.0 (12.1)

60.2 (12.3)

57.9 (13.5)

56.6 (13.6)

Female, n (%)

82 (80.4)

166 (72.2)

98 (80.3)

1520 (77.3)

Disease duration, years

14.1 (9.6)

15.6 (11.0)

14.1 (9.6)

11.6 (10.8)

Baseline HAQ

1.46 (0.61)

1.35 (0.67)

1.43 (0.64)

1.18 (0.64)

Baseline DAS28

5.81 (1.30)

5.30 (1.48)

5.71 (1.32)

5.09 (1.32)

Number of previous biologic courses

2.5 (1.5)

1.8 (1.4)

2.3 (1.4)

0.6 (1.0)

Number of ongoing DMARDs^a

0.7 (1.0)

0.8 (0.6)

0.7 (0.6)

0.9 (0.6)

Ongoing steroids, yes, n (%)

66 (64.7)

156 (67.8)

82 (67.2)

1164 (59.2)